Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70726 - 70750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	GFPT2	9945	upregulated	Silicon Dioxide analog results in increased expression of GFPT2 mRNA	5q35.3	A24194 A24195
Silicon dioxide	Approved	GGA1	26088	upregulated	Silicon Dioxide analog results in increased expression of GGA1 mRNA	22q13.1	A24195
Silicon dioxide	Approved	GGNBP1	449520	downregulated	Silicon Dioxide analog results in decreased expression of GGNBP1 mRNA	6p21.31	A24195
Silicon dioxide	Approved	GGT8P	645367	downregulated	Silicon Dioxide analog results in decreased expression of GGT8P mRNA	2p11.2	A24194
Silicon dioxide	Approved	GH2	2689	downregulated	Silicon Dioxide analog results in decreased expression of GH2 mRNA	17q23.3	A24195
Silicon dioxide	Approved	GH2	2689	upregulated	Silicon Dioxide analog results in increased expression of GH2 mRNA	17q23.3	A24195
Silicon dioxide	Approved	GHDC	84514	downregulated	Silicon Dioxide analog results in decreased expression of GHDC mRNA	17q21.2	A24195
Silicon dioxide	Approved	GHR	2690	downregulated	Silicon Dioxide results in decreased expression of GHR mRNA	5p13.1-p12	A24197 A24196
Silicon dioxide	Approved	GHRLOS	100126793	upregulated	Silicon Dioxide analog results in increased expression of GHRLOS mRNA	3p25.3	A24195
Silicon dioxide	Approved	GIMAP5	55340	upregulated	Silicon Dioxide analog results in increased expression of GIMAP5 mRNA	7q36.1	A24194
Silicon dioxide	Approved	GINS1	9837	downregulated	Silicon Dioxide analog results in decreased expression of GINS1 mRNA	20p11.21	A24194
Silicon dioxide	Approved	GINS2	51659	downregulated	Silicon Dioxide analog results in decreased expression of GINS2 mRNA	16q24.1	A24194
Silicon dioxide	Approved	GIP	2695	downregulated	Silicon Dioxide analog results in decreased expression of GIP mRNA	17q21.32	A24195
Silicon dioxide	Approved	GJA4	2701	upregulated	Silicon Dioxide analog results in increased expression of GJA4 mRNA	1p34.3	A24194
Silicon dioxide	Approved	GJA5	2702	upregulated	Silicon Dioxide analog results in increased expression of GJA5 mRNA	1q21.2	A24194
Silicon dioxide	Approved	GJB1	2705	downregulated	Silicon Dioxide analog results in decreased expression of GJB1 mRNA	Xq13.1	A24195
Silicon dioxide	Approved	GJB2	2706	downregulated	Silicon Dioxide analog results in decreased expression of GJB2 mRNA	13q12.11	A24195
Silicon dioxide	Approved	GJB3	2707	upregulated	Silicon Dioxide analog results in increased expression of GJB3 mRNA	1p34.3	A24195
Silicon dioxide	Approved	GJC3	349149	upregulated	Silicon Dioxide analog results in increased expression of GJC3 mRNA	7q22.1	A24195
Silicon dioxide	Approved	GJD2	57369	upregulated	Silicon Dioxide analog results in increased expression of GJD2 mRNA	15q14	A24194
Silicon dioxide	Approved	GK	2710	downregulated	Silicon Dioxide results in decreased expression of GK mRNA	Xp21.2	A24196
Silicon dioxide	Approved	GKN1	56287	upregulated	Silicon Dioxide analog results in increased expression of GKN1 mRNA	2p13.3	A24195
Silicon dioxide	Approved	GKN2	200504	upregulated	Silicon Dioxide analog results in increased expression of GKN2 mRNA	2p13.3	A24195
Silicon dioxide	Approved	GLB1	2720	downregulated	Silicon Dioxide analog results in decreased expression of GLB1 mRNA	3p22.3	A24195
Silicon dioxide	Approved	GLI1	2735	downregulated	Silicon Dioxide analog results in decreased expression of GLI1 mRNA	12q13.3	A24195

Displaying entries 70726 - 70750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability